<DOC>
	<DOC>NCT00661765</DOC>
	<brief_summary>1. To evaluate the absorption and elimination of varenicline Formulation A transdermal delivery system [TDS (patch)] compared to varenicline immediate release tablet (CHANTIX®). 2. To evaluate the adhesion of the varenicline Formulation A patch. 3. To evaluate the safety and tolerability of a single application of the varenicline patch and a single oral dose of the varenicline immediate release tablet (CHANTIX®).</brief_summary>
	<brief_title>A Single Dose Study Investigating the Absorption and Elimination as Well as the Tolerability of Varenicline Transdermal Delivery System (e.g., a Patch) as Compared to Oral Varenicline in Adult Smokers.</brief_title>
	<detailed_description />
	<mesh_term>Varenicline</mesh_term>
	<criteria>healthy adult smokers Significant blood, kidney, lung, gastrointestinal, heart, liver, psychiatric, or neurologic disease Illegal drug usage</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>varenicline bioavailability transdermal smoking cessation</keyword>
</DOC>